Profitelligence Profitelligence · Filing Ledger Open MDT research →

Form 8-K · Current Report · Filed 2026-04-24

Medtronic Discloses Unauthorized Access to IT Systems

On April 24, 2026, Medtronic plc announced that an unauthorized third party had accessed data in certain of the Company's information technology systems.

Filer
Medtronic plc MDT · NYSE
Filed
Accession
0001628280-26-027272
CIK
0001613103
Signal
High impactHealthcare

Details

The company promptly took steps to contain the incident, activated its incident response protocols, and engaged leading external cybersecurity experts to support its investigation and remediation efforts. Medtronic has not identified any impact to its products, patient safety, connections to customers, manufacturing and distribution operations, financial reporting systems, or ability to meet patient needs. The company does not currently expect the incident to have a material impact on its business or financial results. A statement on the matter was issued on the company's website on April 24, 2026.

Items reported

Item events

Reported Item

Regulatory Investigation New Debt Issued

Market reaction

Close before filing

$83.79

Next session

-1.0%

Since filing

+1.9%

Latest close

$85.39

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from MDT reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, MDT insiders reported 19 Form 4 transactions — net selling of $5.3M.

Full MDT insider history →

About Medtronic plc

Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function of Medtronic is to improve healthcare outcomes by providing advanced therapeutic solutions. Its extensive product portfolio includes cardiac and vascular devices, diabetes-related products, minimally invasive therapies, and neurosurgical technologies. Medtronic plays a vital role in the medical device industry, catering to cardiovascular treatment, advanced diabetes management, spinal and musculoskeletal therapy, and more. Notably, the company is renowned for its pacemaker technology and is a pivotal player in cardiac care. The company's innovations significantly impact the healthcare sector by enhancing the quality of life for patients worldwide and improving the effectiveness of medical treatments. As a key player in the medical device market, Medtronic is instrumental in setting industry standards and advancing medical technology through continuous research and development. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic's global presence underscores its substantial contribution to the healthcare industry across various continents.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another MDT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts